FDA Approves First Functional Cure for Chronic Hepatitis B
The FDA approved the first functional cure for chronic Hepatitis B, currently for patients without cirrhosis — a landmark medical milestone.
What we know
An account on X flagged the breaking FDA approval of the first functional Hepatitis B cure, a disease affecting ~300 million people worldwide. The approval is currently scoped to patients without cirrhosis. This intersects with broader CT interest in longevity and biotech — another account on X noted crypto billionaires including CZ (Yzi Labs ~$1B in biotech) and Brian Armstrong (Newlimit, $3.1B) are actively pivoting capital into this sector after AI.
By the Global Eye 24 desk, with AI assistance. Updated as the story develops. Spot an error? Write to corrections@globaleye24.com.